DSHEA%20and%20Bioavailability - PowerPoint PPT Presentation

About This Presentation
Title:

DSHEA%20and%20Bioavailability

Description:

Folic acid and neural tube defects. Meet USP standards: dissolution & disintegration ... Example: Folic acid. Applicability to other ingredients? Safety and ... – PowerPoint PPT presentation

Number of Views:72
Avg rating:3.0/5.0
Slides: 34
Provided by: elizabet115
Learn more at: http://www.lsro.org
Category:

less

Transcript and Presenter's Notes

Title: DSHEA%20and%20Bioavailability


1
DSHEA and Bioavailability
  • Elizabeth A. Yetley, Ph.D.
  • Ctr. Food Safety Applied Nutrition
  • Food and Drug Administration

2
Approach
  • Regulatory Applications
  • How has concept been applied?
  • General characteristics
  • Specific questions for dietary supplements
  • Science and research needs

3
Regulatory Applications
4
Regulatory Experience
  • Drugs -- separate regulations
  • Foods -- case-by-case
  • Safety
  • Labeling

5
Food Safety -- Bioavailability
  • Safety
  • Food additive authorizations
  • GRAS status
  • GMPs
  • Infant formula quality factors

6
Safety Example Food Additive
  • Olestra
  • Must add fat soluble vitamins
  • Label information required

7
Safety Example -- GRAS
  • GRAS -- Nutrients
  • Amounts not in excess of that required to produce
    intended effect
  • Levels not to exceed GMPs

8
Safety Example -- Finished Products
  • Calcium and iron supplements
  • Less effective than expected
  • High doses of selenium -- low toxicity
  • Contaminants
  • Mercury
  • Lead in calcium supplements

9
Safety Example-- Infant Formula
  • Infant formula Quality Factors
  • Statutory requirement
  • Failure to meet --gt adulteration
  • Proposed definition

10
Food Labeling -- Bioavailability
  • Label information
  • Nutrition or Supplement Facts declarations
  • Claims
  • Enriched products

11
Label declarations -- History
  • Based on analytical amounts
  • Nutrients
  • Derived from 1968 RDAs
  • 1968 RDAs -- some correction for
    bioavailability
  • FDAs compliance method for some nutrients --
    microbiological assay

12
Label declarations -- History
  • Calorie content
  • May use specific Atwater factors
  • May use specific food factors
  • Correct for insoluble dietary fiber
  • Correct for protein indigestibility

13
Label Declarations -- History
  • Non-nutrients
  • No correction for bioavailability

14
Claims -- History
  • Truthful and not misleading
  • Meets regulations
  • More claims gt 10 RDI

15
Health claims -- History
  • Calcium and osteoporosis
  • Folic acid and neural tube defects
  • Meet USP standards dissolution disintegration
  • Calcium assimilable

16
Enriched products -- History
  • Nutrient -- physiologically available
  • Level --gt not result in excessive intake
  • Nutrient -- suitable for intended purpose

17
Enriched products -- History
  • Iron and Calcium
  • Safe and suitable, or
  • Harmless and assimilable
  • Research
  • Predictive validity of animal bioassays
  • Identification relative bioavailability of
    ingredient sources

18
General principles -- History
  • Affects both safety and effectiveness
  • Case-by-case
  • Physiological effects, not just absorption
  • Linked to intended use
  • Amounts not to exceed intended effects
  • Not to deceive consumer

19
Current Marketed D.S. Products
20
Ingredients
  • Vitamins and minerals
  • Macronutrients
  • Botanicals
  • Amino Acids
  • Substances intended to supplement the diet

21
Potential Bioavailability Issues
  • Source ingredient
  • Extraction and processing procedures
  • Interactions -- active constituents
  • Effects of inert ingredients/coatings
  • Interactions
  • with diet
  • with drugs

22
Next Steps -- Science Research
23
Issues to be addressed
  • Definition What is it?
  • Compliance (analytical) methods?
  • Specific regulatory impacts
  • Safety requirements?
  • Label information?
  • GMPs?

24
Definition Why Discuss?
  • When to consider bioavailability?
  • How to monitor compliance?
  • Substantiation or documentation?

25
Definition
  • Absorption?
  • Digestion?
  • Metabolism?
  • Excretion?
  • Summary Utilization?

26
Definitional Challenges?
  • Case by case vs. general?
  • Ingredient vs. finished product?

27
Definitional Challenges?
  • New RDIs based on equivalents
  • Example Folic acid
  • Applicability to other ingredients?

28
Definitional Challenges?
  • New Upper Limits based on synthetics
  • Example Folic acid
  • Applicability to other ingredients?

29
Safety and Effectiveness Challenges
  • How to deal with exposure levels
  • Effectiveness
  • Safety
  • Safety factors for uncertainty

30
Host and Use Challenges
  • Label information
  • Appropriate use conditions
  • Vulnerable populations
  • Consumer right to know issues

31
Other Challenges
  • Effect of processing?
  • Effect of storage?

32
Science and Research Needs
  • Bioavailability High priority research need for
    CFSAN
  • Definition
  • Analytical methods
  • Meaningfulness of measures

33
Key issue
  • On food - drug continuum
  • Where do dietary supplements fall relative to
    bioavailability?
Write a Comment
User Comments (0)
About PowerShow.com